CureVac NVNASDAQ:CVAC
No Matches were found for
- LAST PRICE2.5150
- TODAY'S CHANGE (%)-0.1550 (-5.8052%)
- Bid / Lots2.5100/ 11
- Ask / Lots2.5200/ 8
- Open / Previous Close2.6600 / 2.6700
- Day Range
- 52 Week Range
- Volume882,306
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CVAC |
|---|---|---|
| 09:32 ET | 6838 | 2.64 |
| 09:33 ET | 4340 | 2.65 |
| 09:35 ET | 2557 | 2.645 |
| 09:37 ET | 59726 | 2.61 |
| 09:39 ET | 6500 | 2.61 |
| 09:42 ET | 900 | 2.61 |
| 09:44 ET | 21164 | 2.62 |
| 09:46 ET | 18128 | 2.67 |
| 09:48 ET | 4525 | 2.66 |
| 09:50 ET | 24094 | 2.6401 |
| 09:51 ET | 7549 | 2.625 |
| 09:53 ET | 38550 | 2.57 |
| 09:55 ET | 6120 | 2.582 |
| 09:57 ET | 3065 | 2.5807 |
| 10:00 ET | 5249 | 2.6 |
| 10:02 ET | 41134 | 2.61 |
| 10:04 ET | 13657 | 2.585 |
| 10:06 ET | 18448 | 2.58 |
| 10:08 ET | 48060 | 2.55 |
| 10:09 ET | 19156 | 2.555 |
| 10:11 ET | 41411 | 2.55 |
| 10:13 ET | 27893 | 2.545 |
| 10:15 ET | 14998 | 2.53 |
| 10:18 ET | 48869 | 2.52 |
| 10:20 ET | 6487 | 2.525 |
| 10:22 ET | 100 | 2.5299 |
| 10:24 ET | 23192 | 2.545 |
| 10:26 ET | 1748 | 2.53 |
| 10:27 ET | 32220 | 2.5209 |
| 10:29 ET | 17323 | 2.52 |
| 10:31 ET | 22477 | 2.55 |
| 10:33 ET | 1240 | 2.54 |
| 10:36 ET | 2725 | 2.53 |
| 10:38 ET | 3551 | 2.52 |
| 10:40 ET | 500 | 2.53 |
| 10:42 ET | 1800 | 2.525 |
| 10:44 ET | 200 | 2.52 |
| 10:45 ET | 9397 | 2.515 |
| 10:47 ET | 500 | 2.515 |
| 10:49 ET | 823 | 2.515 |
| 10:56 ET | 7940 | 2.535 |
| 10:58 ET | 1600 | 2.54 |
| 11:00 ET | 700 | 2.53 |
| 11:02 ET | 210 | 2.526304 |
| 11:03 ET | 700 | 2.53 |
| 11:05 ET | 3014 | 2.53293 |
| 11:07 ET | 3151 | 2.53 |
| 11:09 ET | 4007 | 2.54 |
| 11:12 ET | 2300 | 2.525 |
| 11:14 ET | 5736 | 2.535 |
| 11:16 ET | 2242 | 2.545 |
| 11:18 ET | 914 | 2.567071 |
| 11:20 ET | 450 | 2.5645 |
| 11:21 ET | 300 | 2.5693 |
| 11:23 ET | 769 | 2.565 |
| 11:25 ET | 400 | 2.57 |
| 11:27 ET | 700 | 2.59 |
| 11:30 ET | 750 | 2.5801 |
| 11:32 ET | 10154 | 2.605 |
| 11:34 ET | 2100 | 2.6 |
| 11:36 ET | 8169 | 2.565 |
| 11:38 ET | 1225 | 2.5609 |
| 11:41 ET | 553 | 2.555 |
| 11:43 ET | 7806 | 2.555 |
| 11:50 ET | 350 | 2.555 |
| 11:52 ET | 9934 | 2.545 |
| 11:54 ET | 2595 | 2.555 |
| 11:56 ET | 400 | 2.56 |
| 11:57 ET | 100 | 2.565 |
| 12:01 ET | 242 | 2.565 |
| 12:08 ET | 100 | 2.565 |
| 12:10 ET | 100 | 2.565 |
| 12:12 ET | 300 | 2.56 |
| 12:14 ET | 282 | 2.56 |
| 12:17 ET | 100 | 2.55 |
| 12:19 ET | 245 | 2.5509 |
| 12:26 ET | 322 | 2.555 |
| 12:30 ET | 122 | 2.555 |
| 12:32 ET | 100 | 2.555 |
| 12:33 ET | 500 | 2.555 |
| 12:37 ET | 106 | 2.551 |
| 12:39 ET | 889 | 2.56 |
| 12:44 ET | 1882 | 2.55 |
| 12:46 ET | 1713 | 2.54 |
| 12:48 ET | 400 | 2.545 |
| 12:50 ET | 21092 | 2.54 |
| 12:51 ET | 31944 | 2.5 |
| 12:53 ET | 1333 | 2.5 |
| 12:55 ET | 700 | 2.5 |
| 12:57 ET | 941 | 2.5 |
| 01:00 ET | 650 | 2.5 |
| 01:02 ET | 826 | 2.5 |
| 01:04 ET | 400 | 2.5 |
| 01:06 ET | 200 | 2.505 |
| 01:08 ET | 200 | 2.5 |
| 01:09 ET | 13784 | 2.505 |
| 01:11 ET | 600 | 2.515 |
| 01:13 ET | 200 | 2.52 |
| 01:15 ET | 1100 | 2.525 |
| 01:18 ET | 500 | 2.525 |
| 01:20 ET | 8543 | 2.525 |
| 01:26 ET | 450 | 2.525 |
| 01:29 ET | 800 | 2.54 |
| 01:31 ET | 2288 | 2.535 |
| 01:38 ET | 1665 | 2.545 |
| 01:40 ET | 200 | 2.545 |
| 01:42 ET | 10097 | 2.535 |
| 01:44 ET | 100 | 2.535 |
| 01:45 ET | 200 | 2.54 |
| 01:49 ET | 250 | 2.535 |
| 01:51 ET | 100 | 2.535 |
| 01:56 ET | 2600 | 2.535 |
| 02:00 ET | 200 | 2.54 |
| 02:02 ET | 700 | 2.545 |
| 02:03 ET | 1716 | 2.535 |
| 02:07 ET | 1236 | 2.535 |
| 02:09 ET | 664 | 2.535 |
| 02:12 ET | 100 | 2.535 |
| 02:16 ET | 1870 | 2.5209 |
| 02:20 ET | 110 | 2.52 |
| 02:21 ET | 1526 | 2.515 |
| 02:23 ET | 2995 | 2.515 |
| 02:25 ET | 3362 | 2.51 |
| 02:27 ET | 1100 | 2.515 |
| 02:30 ET | 200 | 2.515 |
| 02:32 ET | 100 | 2.515 |
| 02:34 ET | 200 | 2.51 |
| 02:38 ET | 100 | 2.515 |
| 02:39 ET | 4200 | 2.515 |
| 02:41 ET | 100 | 2.515 |
| 02:43 ET | 2368 | 2.515 |
Nov 12, 2024
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update, from 7:23AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:23AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024, from 7:56AM ET on Thursday Nov 07, 2024 by Dow Jones
7:56AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 4, 2024
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer, from 7:21AM ET on Monday Nov 04, 2024 by Dow Jones
7:21AM ET on Monday Nov 04, 2024 by Dow JonesCureVac to Present at the 12th International mRNA Health Conference, from 7:17AM ET on Monday Nov 04, 2024 by Dow Jones
7:17AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 28, 2024
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, from 8:30AM ET on Monday Oct 28, 2024 by Dow Jones
8:30AM ET on Monday Oct 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CureVac NV | 598.9M | -1.9x | --- |
Zenas Biopharma Inc | 745.3M | -12.8x | --- |
Chromadex Corp | 550.0M | 365.6x | --- |
Contineum Therapeutics Inc | 467.9M | -12.3x | --- |
Regenxbio Inc | 551.9M | -2.0x | --- |
Y-mAbs Therapeutics Inc | 516.6M | -20.1x | --- |
Company Information
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Contact Information
- Headquarters
- Friedrich-Miescher-Str. 15TUEBINGEN, Germany 72076
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of Supervisory Board
- Baron Stephenne
- Chief Executive Officer, Member of the Management Board
- Alexander Zehnder
- Chief Financial Officer
- Axel-Sven Malkomes
- Chief Operating Officer, Member of the Management Board
- Malte Greune
- Chief Commercial Officer, Member of the Management Board
- Antony Blanc
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $598.9M |
|---|---|
Revenue (TTM) | $69.3M |
Shares Outstanding | 224.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.59 |
EPS | $-1.31 |
Book Value | $2.43 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 8.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -438.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
